Mamata Mishra

Dr. Mamata Mishra

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2026 in Stem Cell Reviews and Reports
Verified
Journal Article
Closed access
PDF file
DSDebraj Shome
Debraj Shome
MMMamata Mishra
Mamata Mishra
APAshwin Prabhughate
Ashwin Prabhughate
DBDepti Bellani
Depti Bellani
RPRaji Patil
Raji Patil
RKRinky Kapoor
Rinky Kapoor

16 December 2025 in ADMET and DMPK
Verified
Journal Article
Open access
PDF file
RKRinky Kapoor
Rinky Kapoor
DBDepti Bellani
Depti Bellani
RPRaji Patil
Raji Patil
DBDebalina Bose
Debalina Bose
MPMadhuri Pola
Madhuri Pola
DSDebraj Shome
Debraj Shome
Background and purpose: Non-scarring alopecia, principally androgenetic alopecia and alopecia areata is highly prevalent and psychologically burdensome; androgenetic alopecia is androgen-driven, whereas alopecia areata is autoimmune. This review synthesizes genetic architecture and pathway biology to outline a precision framework for targeted interventions. Experimental approach: We reviewed full-text studies from the past decade across PubMed, Web of Science and Google Scholar, applying explicit inclusion/ex­clusion criteria; emphasis was placed on Genome wide association studies and Next generation sequencing findings, immune and androgen-axis biology, environmental modifiers, and therapeutic evidence (conven­tional, targeted, and regenerative), alongside artificial Intelligence-enabled diagnostics. Key results: Andro­genetic alopecia risk converges on androgen-receptor signalling and related loci, with perifollicular inflam­mation and oxidative stress as modifiers; finasteride remains a cornerstone therapy. Alopecia areata reflects polygenic immune dysregulation (e.g. Human leukocyte antigen/cytokine axes) with Janus Kinase-pathway inhibition yielding robust regrowth; across phenotypes, wingless-related integration sit/β-catenin and stem-cell programs are central targets. Regenerative options (Protein Rich Plasma, stem-cell/exosome appro­aches) and artificial Intelligence-assisted stratification are emerging adjuncts. Conclusion: A pathway-guided, genotype and phenotype-informed strategy, targeting the androgen axis for androgenetic alopecia, immune circuits for alopecia areata, and adding regenerative or microenvironmental therapies where indicated-promises earlier diagnosis and more durable, individualized outcomes, especially as genome-wide association study/next-generation sequencing and artificial Intelligence tools are integrated into care.

28 March 2026 in Stem Cell Reviews and Reports
Verified
Journal Article
Closed access
PDF file
MMMamata Mishra
Mamata Mishra
MAMohammad Abdulkader Akbarsha
Mohammad Abdulkader Akbarsha
RKRinky Kapoor
Rinky Kapoor
DSDebraj Shome
Debraj Shome

11 September 2026 in Stem Cell Reviews and Reports
Verified
Journal Article
Closed access
PDF file
MMMamata Mishra
Mamata Mishra
RKRinky Kapoor
Rinky Kapoor
PSPankaj Seth
Pankaj Seth
APAshwin Prabhughate
Ashwin Prabhughate
DSDebraj Shome
Debraj Shome

29 August 2026 in Stem Cell Reviews and Reports
Verified
Journal Article
Closed access
PDF file
MMMamata Mishra
Mamata Mishra
RKRinky Kapoor
Rinky Kapoor
KKKhushbu Kumari
Khushbu Kumari
DSDebraj Shome
Debraj Shome

20 January 2026 in Stem Cell Reviews and Reports
Verified
Journal Article
Closed access
PDF file
MMMamata Mishra
Mamata Mishra
RKRinky Kapoor
Rinky Kapoor
PSPankaj Seth
Pankaj Seth
RPRaji Patil
Raji Patil
DSDebraj Shome
Debraj Shome